BlackRock »

Monte Rosa Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $15M 2.9M 5.30

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Monte Rosa Therapeutics

NEA Management Company
T. Rowe Price Associates
Baker Bros. Advisors
BlackRock
Suvretta Capital Management
Vanguard Group
BlackRock
Aisling Capital Management
Alphabet
Citadel Advisors
Geode Capital Management
Vestal Point Capital
State Street Corporation
Parkwood
ExodusPoint Capital Management

View all funds holding Monte Rosa Therapeutics